DBV Technologies (DBVT) Common Equity (2015 - 2026)
DBV Technologies (DBVT) posted Common Equity of $160.4 million for Q2 2026, up 86.1% from $86.2 million a year earlier but down 22.8% from the prior quarter.
DBV Technologies (DBVT) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, DBV Technologies' Common Equity came in at $168.8 million, up 516.1% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -3.9% (FY2020 to FY2025).
- In prior years, DBV Technologies' Common Equity was $27.4 million in FY2024 (-80.5%), $140.19 million in FY2023 (-27.9%), $194.45 million in FY2022 (+95.9%) and $99.27 million in FY2021 (-51.7%).
- Quarterly Common Equity has run from a low of $2.9 million in Q1 2025 to a high of $244.42 million in Q2 2022 over five years.
- On a year-over-year basis, Common Equity increased in three of the last seven quarters, with growth averaging 52.7%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2025, with growth of 516.1%; the weakest was Q1 2025, with a decline of 97.4%.
- According to Business Quant data, Common Equity for the three prior quarters was $207.9 million (Q1 2026), $168.8 million (Q4 2025) and $52.85 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | DBV Technologies | 5.05 Bn | 4.38 Bn | - | 160.40 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160.40 Mn |
| Mar 31, 2026 | 207.90 Mn |
| Dec 31, 2025 | 168.80 Mn |
| Sep 30, 2025 | 52.85 Mn |
| Jun 30, 2025 | 86.20 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 27.40 Mn |
| Sep 30, 2024 | 54.03 Mn |
| Jun 30, 2024 | 79.10 Mn |
| Mar 31, 2024 | 111.65 Mn |
| Dec 31, 2023 | 140.19 Mn |
| Sep 30, 2023 | 143.99 Mn |
| Jun 30, 2023 | 164.24 Mn |
| Mar 31, 2023 | 179.09 Mn |
| Dec 31, 2022 | 194.45 Mn |
| Sep 30, 2022 | 212.05 Mn |
| Jun 30, 2022 | 244.42 Mn |
| Mar 31, 2022 | 82.06 Mn |
| Dec 31, 2021 | 99.27 Mn |
| Sep 30, 2021 | 116.89 Mn |
DBV Technologies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DBVT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DBVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DBVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();